Four New Clinical Trials Available at Texas Retina Associates
Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Dr. Abbey Presented National Webinar on Treatment of Patients with Diabetic Macular Edema and 20/50 or Worse Vision
On Monday, September 19, 2022, Texas Retina Associates’ Ashkan M. Abbey, MD, delivered a webinar titled, “Does Treatment Selection Matter in Patients with Diabetic Macular Edema and 20/50 or Worse Vision?” Dr. Abbey discussed
read more Dr. Abbey Presented Preliminary Findings of a Diabetic Macular Edema Clinical Trial at the Retina World Congress
Texas Retina Associates’ Ashkan M. Abbey, MD served as an invited faculty member for the Retina World Congress held May 12-15, 2022, in Fort Lauderdale, Florida. This global physician meeting featured presentations
read more
Dr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video
In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in
read more
Dr. Kothari and Dr. Abbey Earn “Top 10 Poster Award” at American Society of Retina Specialists 2021 Annual Scientific Meeting
A research poster by Texas Retina Associates physicians Nikisha Kothari, MD, and Ashkan M. Abbey, MD, was awarded “Top 10” honors at the American Society of Retina Specialists (ASRS) 2021 Annual Scientific
read more
New Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Clinical Trials Help Uncover New Sight-Saving Treatment Options
At Texas Retina Associates, our physicians are committed to continually improving care for our patients, and a big part of that involves conducting ongoing research of potential new sight-saving retina treatments. Clinical
read more
What You Should Know About Nonproliferative Diabetic Retinopathy (NPDR)
By Ivan G. Castillo, MD November is National Diabetes Month. If you have diabetes mellitus, your body does not use and store glucose properly. Over time, diabetes can damage all of the
read more